Huge response to PLI Scheme for bulk drugs, medical devices
30 Nov 2020
1
The central scheme for providing Production Linked Incentive (PLI) for setting up units for production of bulk drugs and medical devices has received very encouraging response from the pharmaceutical as well as the medical device industry.
The PLI scheme for bulk drugs has received 247 registrations across all four categories of products, out of which a maximum of 136 applicants will be selected under the scheme.
Similarly, the PLI scheme for medical devices has received 28 registrations across all four target segments, out of which a maximum of 28 applicants will be selected under the scheme.
IFCI Ltd is the project management agency for the schemes and all the applications are being received on its online portal.
The last date of filing the application under both the schemes is 30 November 2020.
The government has advised current and prospective registrants are advised that in view of bank holidays from 28 November 2020 to 30 November 2020, the payment of application fee may be done through the NEFT mode. The details of the bank accounts are mentioned in the respective guidelines. The team of IFCI Ltd will be available till last date of applications on the contact details mentioned on their website, to assist the applicants, it added.
The government approved the PLI Scheme for bulk drugs and for medical devices on 20 March 2020. The guidelines for implementation of both the schemes were issued on 27 July 2020 and were revised later based on the feedback received from the industry. The revised guidelines were issued on 29 October 2020.
.jpg "RBI keeps repo rate unchanged as focus remains on inflation")
.jpg "Indian Oil, Panasonic team up for lithium-ion cell production in India")
